On December 14, 2022, Medifron DBT Co., Ltd. closed the transaction. The company issued 3,427,600 shares in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,206 KRW | +1.26% | +3.61% | -27.91% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,480 KRW | +3.93% | +13.85% | 67.53M | ||
1,206 KRW | +1.26% | +3.61% | 59.7M | ||
1st Jan change | Capi. | |
---|---|---|
-27.91% | 59.7M | |
-14.25% | 189B | |
+0.72% | 166B | |
+1.62% | 152B | |
+3.83% | 99.37B | |
+5.85% | 77.36B | |
+14.58% | 70.76B | |
-7.93% | 70.46B | |
-22.01% | 51.83B | |
-6.79% | 44.34B |
- Stock Market
- Equities
- A057680 Stock
- News T Scientific Co.,Ltd.
- Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd